Lim Suhsien, Muhs Bart E, Marcus Stuart G, Newman Elliot, Berman Russel S, Hiotis Spiros P
Department of Surgery, Bellevue Hospital/New York University School of Medicine, New York, New York 10016, USA.
J Surg Oncol. 2007 Feb 1;95(2):118-22. doi: 10.1002/jso.20328.
Patients who present with stage IV gastric cancer are not commonly managed with surgical resection as effective palliation can usually be accomplished with systemic chemotherapy, endoscopic stenting, or surgical bypass procedures. Given the inherent morbidity and mortality associated with gastrectomy, palliative resection for stage IV gastric cancer should be reserved for ideal surgical candidates who are most likely to benefit from the procedure. The purpose of this study is to review outcomes following resection for stage IV gastric cancer, and to identify criteria predictive of improved outcomes following gastrectomy in this setting.
A retrospective review of a prospective GI oncology database was conducted. Sixty-three patients with stage IV gastric cancer managed with surgical resection between 1989 and 2001 were identified. Variables including demographic data, patterns of distant spread (ex: peritoneal, lymphatic, hematogenous), location of tumor, and type of gastrectomy were utilized to conduct survival analyses.
Actuarial survival for all patients at one and 3-year intervals was 52% and 12%, respectively. Improved survival was observed for patients of East Asian race (median survival 20 vs. 12 months, P < 0.05, students t-test) and age less than 60 years (median survival 15 vs. 12 months, P < 0.05). This trend was also illustrated by Kaplan-Meier survival analysis. Other variables including pattern of distant spread, location of tumor, and type of gastrectomy were not associated with a significant difference in survival. Both East Asian race and age less than 60 years were statistically significant predictors of improved survival when assessed by univariate regression analysis. When variables were analyzed in a multivariate regression analysis, Asian race and age <60 both lost their statistical significance as independent predictors of improved survival.
Long-term survival for patients with stage IV gastric cancer who are managed with surgical resection is achievable. Patient specific variables including East Asian race and age less than 60 years appear to be associated with prolonged survival when assessed by comparison of means, Kaplan-Meier analysis, and univariate regression analysis. However, multivariate regression analysis failed to demonstrate these factors as independent predictors of improved outcome. In conclusion, highly selected acceptable risk surgical candidates with stage IV gastric cancer should be considered for management with surgical resection in clinically appropriate scenarios.
IV期胃癌患者通常不采用手术切除治疗,因为全身化疗、内镜支架置入或手术旁路手术通常可实现有效的姑息治疗。鉴于胃切除术固有的发病率和死亡率,IV期胃癌的姑息性切除应仅适用于最有可能从该手术中获益的理想手术候选人。本研究的目的是回顾IV期胃癌切除术后的结果,并确定在此情况下预测胃切除术后预后改善的标准。
对一个前瞻性胃肠肿瘤数据库进行回顾性分析。确定了1989年至2001年间接受手术切除的63例IV期胃癌患者。利用包括人口统计学数据、远处转移模式(如:腹膜、淋巴、血行)、肿瘤位置和胃切除类型等变量进行生存分析。
所有患者1年和3年的精算生存率分别为52%和12%。东亚种族患者(中位生存期20个月对12个月,P<0.05,学生t检验)和年龄小于60岁的患者(中位生存期15个月对12个月,P<0.05)的生存率有所提高。Kaplan-Meier生存分析也显示了这一趋势。其他变量,包括远处转移模式、肿瘤位置和胃切除类型,与生存率的显著差异无关。通过单因素回归分析评估时,东亚种族和年龄小于60岁均为生存率提高的统计学显著预测因素。在多因素回归分析中分析变量时,亚洲种族和年龄<60岁作为生存率提高的独立预测因素均失去了统计学意义。
接受手术切除的IV期胃癌患者可实现长期生存。通过均值比较、Kaplan-Meier分析和单因素回归分析评估时,包括东亚种族和年龄小于60岁在内的患者特异性变量似乎与生存期延长有关。然而,多因素回归分析未能证明这些因素是预后改善的独立预测因素。总之,在临床合适的情况下,对于高度选择的可接受风险的IV期胃癌手术候选人,应考虑手术切除治疗。